Multiple Myeloma

Showing NaN - NaN of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Worldwide (Lenalidomide)

Completed
  • Multiple Myeloma
  • Baudour, Belgium
  • +72 more
Apr 13, 2021

Multiple Myeloma Trial in Worldwide (Bortezomib, Melphalan, Prednisone (VMP), 1 or 2 cycle(s) HDM (High Dose Melphalan), 2

Active, not recruiting
  • Multiple Myeloma
  • Bortezomib, Melphalan, Prednisone (VMP)
  • +2 more
  • Brisbane, Australia
  • +207 more
Mar 22, 2021

Irradiated Bone Marrow, Transplant-Related Hematologic Malignancy, Leukemia, Acute Trial in Milano (Conditioning treatment

Terminated
  • Irradiated Bone Marrow
  • +4 more
  • Conditioning treatment "Treosulfan-TMI"
  • +2 more
  • Milano, Lombardia, Italy
    Ospedale San Raffaele
Oct 13, 2020

Multiple Myeloma Trial in Worldwide (Panobinostat, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Phoenix, Arizona
  • +209 more
Mar 8, 2020

Multiple Myeloma Trial in Worldwide (Lenalidomide and low-dose dexamethasone, Lenalidomide plus low-dose dexamethasone given for

Completed
  • Multiple Myeloma
  • Lenalidomide and low-dose dexamethasone
  • +2 more
  • Birmingham, Alabama
  • +287 more
Nov 7, 2019

Multiple Myeloma Trial in Worldwide (Placebo, Dexamethasone, Bortezomib)

Completed
  • Multiple Myeloma
  • Placebo
  • +3 more
  • Tucson, Arizona
  • +56 more
Sep 25, 2019

Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

Completed
  • Breast Cancer
  • +15 more
  • Encinitas, California
  • +23 more
Sep 20, 2018

Multiple Myeloma Trial in Worldwide (Elotuzumab, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Elotuzumab
  • +2 more
  • Corona, California
  • +76 more
Apr 20, 2018

Multiple Myeloma Trial in Worldwide (CC-5013 plus dexamethasone, Dexamethasone plus Placebo)

Completed
  • Multiple Myeloma
  • CC-5013 plus dexamethasone
  • Dexamethasone plus Placebo
  • Camperdown, New South Wales, Australia
  • +68 more
Sep 18, 2017

Multiple Myeloma Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo, Bortezomib)

Withdrawn
  • Multiple Myeloma
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Scottsdale, Arizona
  • +57 more
Oct 6, 2016

Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes,

Completed
  • Febrile Neutropenia
  • +8 more
    • Innsbruck, Austria
    • +119 more
    Dec 9, 2015

    Multiple Myeloma Trial in Worldwide (NOX-A12)

    Completed
    • Multiple Myeloma
    • Salzburg, Austria
    • +9 more
    Oct 5, 2015

    Multiple Myeloma Trial in Worldwide (A (Thalidomide + Dexamethasone), B (Placebo + Dexamethasone))

    Completed
    • Multiple Myeloma
    • A (Thalidomide + Dexamethasone)
    • B (Placebo + Dexamethasone)
    • Hoover, Alabama
    • +98 more
    Sep 9, 2015

    Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome Trial in Italy (Treosulfan IV)

    Unknown status
    • Leukemia
    • +6 more
    • Treosulfan IV
    • San Giovanni Rotondo, Foggia, Italy
    • +11 more
    Aug 10, 2009